Related by context. All words. (Click for frequent words.) 74 hepatic fibrosis 71 fibrosis 67 anti fibrotic 67 diabetic nephropathy 66 hepatocellular carcinoma 66 HNSCC 66 atherosclerosis 66 colorectal tumors 65 antitumor effect 64 secondary hyperparathyroidism 64 prostate cancer CaP 64 endotoxemia 64 liver scarring 64 breast cancer metastasis 64 reperfusion injury 63 hyperinsulinemia 63 SSc 63 neovascular 63 IL 1ß 63 choroidal neovascularization 63 neuroinflammation 63 endothelial dysfunction 62 lung fibrosis 62 choroidal neovascularization CNV 62 SHPT 62 liver metastasis 62 nonalcoholic steatohepatitis 62 NAFLD 62 neuroprotective effects 62 platelet activation 62 amyloid deposition 62 neurotrophic 62 HER2 overexpression 62 nephropathy 62 PSADT 62 diabetic gastroparesis 62 proliferative diabetic retinopathy 62 geographic atrophy 62 plasma kallikrein 62 myeloperoxidase 62 gastric adenocarcinoma 62 disease progression 62 Alzheimer Disease AD 62 urothelial carcinoma 62 fibrotic disease 61 F FDG PET 61 chemopreventive agent 61 non alcoholic steatohepatitis 61 renal fibrosis 61 pro angiogenic 61 Symadex 61 ADPKD 61 malignant transformation 61 airway hyperresponsiveness 61 atherogenesis 61 atherosclerotic disease 61 TGF β 61 motor neuron degeneration 61 nonalcoholic steatohepatitis NASH 61 atherosclerotic lesions 61 refractory gout 61 carcinogenesis 61 eNOS 61 retinal degeneration 61 Raf MEK ERK 61 vasodilatation 61 gastric carcinogenesis 61 PCa 61 neuronal dysfunction 61 primary biliary cirrhosis 61 diabetic kidney 61 lung metastasis 61 T1DM 61 hypercholesterolemia 61 cardioprotective effects 61 CTAP# Capsules 61 variceal bleeding 61 isoenzyme 61 prostate carcinoma 61 colorectal carcinoma 61 p# activation 61 prognostic markers 61 T2D 61 chemopreventive 61 chronic pancreatitis 61 hepatotoxicity 61 cerebral vasospasm 61 COX2 61 IL 1β 61 TNFa 61 antiproliferative effects 60 Haptoglobin 60 CEACAM1 60 CTGF 60 periodontitis 60 bridging fibrosis 60 neovascularization 60 hepatocellular 60 subclinical atherosclerosis 60 serum urate levels 60 kidney urologic 60 osteoclast activity 60 TNFalpha 60 selective inhibition 60 receptor subtype 60 CYT# potent vascular disrupting 60 prognostic marker 60 microalbuminuria 60 receptor tyrosine kinase inhibitor 60 DFMO 60 gastric cancer 60 hyperalgesia 60 vasculopathy 60 #F FDG PET 60 colorectal cancer CRC 60 VEGF receptor 60 axonal degeneration 60 breast carcinoma 60 urothelial cancer 60 basal cell carcinoma BCC 60 gastric carcinoma 60 E selectin 60 invasive candidiasis 60 p# MAPK 60 cardiac dysfunction 60 PDGFR 60 erythropoietic 60 colorectal adenoma 60 preclinically 60 vaso occlusive crisis 60 prognostic indicator 60 malignant lymphoma 60 prostate carcinogenesis 60 alanine aminotransferase ALT 60 inducible nitric oxide synthase 60 Squalamine 60 pancreatic adenocarcinoma 60 Clusterin 60 T2DM 60 hematopoietic cancers 60 imatinib resistance 60 tumor recurrence 60 systemic fungal infections 60 p tau 60 endometrial hyperplasia 60 bone metastasis 60 serum biomarkers 60 receptor inhibitor 60 tumor regressions 60 mRCC 60 cirrhosis liver failure 60 hepatic steatosis 60 experimentally induced 60 trastuzumab Herceptin ® 60 #beta HSD1 60 cardiac hypertrophy 60 cyclooxygenase 2 60 bone resorption 60 metastatic malignant 60 prostate cancer PCa 59 hyperoxaluria 59 neurodegeneration 59 distant metastasis 59 cartilage degeneration 59 membranous nephropathy 59 microglial activation 59 hepatic cirrhosis 59 transient elastography 59 vidofludimus 59 metastatic cancers 59 fibrotic 59 osteopontin 59 IRX 2 59 antibody mediated 59 nephrotoxicity 59 glutamate neurotransmission 59 macroalbuminuria 59 lactate dehydrogenase 59 transgene expression 59 premalignant lesions 59 PITX2 59 PAOD 59 nonmelanoma skin cancers 59 LPS induced 59 overt nephropathy 59 LRP5 59 arterial calcification 59 gefitinib Iressa 59 insulin resistance 59 mRNA expression 59 Barrett esophagus BE 59 TMEM#B 59 B7 H3 59 CGEN # 59 #ME# 59 K ras mutations 59 cervical lesions 59 kallikrein 59 endometrial cancers 59 INCB# [003] 59 DXL# 59 VEGF expression 59 cachexia 59 fibrosis progression 59 PGE2 59 hepatocellular carcinoma HCC 59 postoperative atrial fibrillation 59 albuminuria 59 dexpramipexole 59 basic fibroblast 59 haematopoietic 59 pharmacologic intervention 59 esophageal squamous cell carcinoma 59 fibrosis scarring 59 GSTP1 59 alkaline phosphatase ALP 59 demethylation 59 mTOR inhibition 59 HIV HCV coinfected 59 Inosine 59 systemic lupus erythematosus 59 leukemia AML 59 prognostic significance 59 OHR/AVR# 59 parkinsonian symptoms 59 Myelodysplastic Syndrome MDS 59 antitumor efficacy 59 neointimal hyperplasia 59 abdominal adiposity 59 Factor VIIa 59 adipogenic 59 aromatase 59 epithelial ovarian cancer 59 pelvic lymphadenectomy 59 diarrhea predominant irritable 59 primary hyperparathyroidism 59 CBLC# 59 NF kB pathway 59 xenograft models 59 Cholangiocarcinoma 59 diabetes mellitus DM 59 renal tumors 59 PPAR γ 59 nasopharyngeal carcinoma 59 node metastases 59 paricalcitol 59 antiangiogenic therapy 59 hippocampal atrophy 59 serum phosphate 59 CVBT #H 59 cardiac fibrosis 59 selective modulator 58 clusterin 58 Cachexia 58 LB# [003] 58 carotid stenosis 58 small molecule activators 58 castrate resistant prostate cancer 58 chronic thromboembolic pulmonary 58 HER2 expression 58 c MYC 58 AA Amyloidosis 58 ventricular remodeling 58 reflux disease 58 mediated inhibition 58 antiplatelet therapies 58 lipid abnormalities 58 cutaneous melanoma 58 IGFBP2 58 E#F# 58 knee osteoarthritis OA 58 kinase inhibition 58 choroidal vasculopathy 58 growth hormone secretion 58 oxidative stress 58 mu opioid receptor antagonist 58 antiangiogenic agent 58 RRM1 58 anti angiogenic therapy 58 carotid atherosclerosis 58 cataract formation 58 riociguat 58 node metastasis 58 biochemical abnormalities 58 metastatic gastric 58 familial amyloidotic polyneuropathy FAP 58 potent inhibitors 58 CP CPPS 58 MEK inhibitor RDEA# 58 essential thrombocythemia 58 neuropathological 58 fibrogenesis 58 anti amnesic 58 receptor antagonism 58 TRO# 58 Helicobacter pylori infection 58 LHRH analogues 58 SGPT 58 artery stenosis 58 IDH1 mutation 58 ON #.Na 58 oral prodrug 58 neuroregenerative 58 renal dysfunction 58 systemic inflammation 58 unresectable tumors 58 hepatocellular cancer 58 LPA1 receptor 58 antiangiogenic 58 probiotic supplementation 58 esophageal carcinoma 58 elevated triglyceride levels 58 scintigraphic 58 lupus nephritis 58 proto oncogene 58 tumorigenesis 58 postoperative AF 58 acid secretion 58 neurogenic 58 skeletal metastases 58 chemosensitivity 58 Rasagiline 58 Sjögren syndrome 58 activin 58 ADAMTS# 58 gastric cancers 58 fatty liver disease 58 atherosclerotic vascular disease 58 antiplatelet agent 58 molecular biomarkers 58 epithelial tumors 58 radiosensitivity 58 tumors GIST 58 Non Alcoholic Fatty 58 NAT2 58 inhibit metastasis 58 alkylating agent 58 neurocognitive deficits 58 TPMT 58 FSAD 58 depsipeptide 58 MGUS 58 inhibitory effects 58 BRAF mutation 58 mecamylamine 58 FDG PET 58 lomitapide 58 breast endometrial 58 liver metastases 58 nNOS 58 thyrotropin 58 immune modulation 58 Akt activation 58 galanin 58 LHRH agonists 58 proteinuria 58 glomerular filtration 58 alpha glucosidase 58 anti CD3 58 Hematologic 58 myeloproliferative disorders 58 post surgical adhesions 58 liver histology 58 virological response 58 atrophic gastritis 58 oncogenesis 58 cobiprostone 58 neuronal differentiation 58 cyclin E 58 vasomotor symptoms 58 postoperative ileus 58 Chronic Prostatitis 58 proinflammatory cytokines 58 HCV infection 58 AA amyloidosis 58 mammary tumors 58 aminotransferases 58 premalignant 58 VEGF inhibitors 58 airway hyper responsiveness 58 acetonide FA 58 schizophrenia CIAS 58 systemic lupus erythematosus SLE 58 Angiotensin converting enzyme 58 hormone refractory 58 Neovascular AMD 58 cMET 58 aortic atherosclerosis 58 atherothrombosis 58 CIN2 + 58 diabetic retinopathy 58 TGF beta signaling 58 PsA 58 intact parathyroid hormone 58 multiple myeloma MM 58 biochemical markers 58 Kupffer cells 58 edifoligide 58 Prodarsan ® 58 FasL 58 Kinoid 58 VAPRISOL 58 ovarian carcinoma 58 HbF 58 coronary calcification 58 BMP signaling 58 pathophysiological mechanisms 58 PI3K inhibitors 57 cervical carcinoma 57 allergic inflammation 57 gene polymorphisms 57 vascular inflammation 57 miRview mets 57 precursor lesions 57 Safinamide 57 intermittent hypoxia 57 tumor necrosis 57 Natalizumab 57 neuro protective 57 infarct size 57 gastrointestinal stromal tumors GIST 57 dose dependently 57 cytoprotective 57 diagnostic biomarker 57 CC genotype 57 presymptomatic 57 micrometastasis 57 autonomic dysfunction 57 Dasatinib 57 AT1R 57 remyelination 57 peritoneal carcinomatosis 57 recurrent miscarriage 57 neoplasia 57 spontaneous bacterial peritonitis 57 TNF antagonist 57 juvenile idiopathic arthritis 57 Gleevec resistant 57 SLC#A# [002] 57 IGF 1R 57 urate levels 57 HIF PHI 57 c myc gene 57 enzymatic activity 57 nerve degeneration 57 FDG PET imaging 57 glycated hemoglobin levels 57 bardoxolone methyl 57 PDGF receptor 57 TRIOLEX 57 pertuzumab 57 fibrin deposition 57 NMIBC 57 platelet function 57 inhibitor RG# 57 Telintra 57 Cardiotoxicity 57 myeloproliferative diseases 57 PTHrP 57 metabolic abnormalities 57 endometrial cancer 57 pathophysiological effects 57 systemic toxicity 57 pulmonary hypertension PH 57 renal toxicity 57 antiangiogenesis 57 alcoholic hepatitis 57 PEDF 57 serum PSA 57 hyperglycaemia 57 uPA 57 pathologic 57 Beta catenin pathway 57 colorectal adenomas 57 Angiotensin II 57 distant metastases 57 chronic periodontitis 57 CYP#D# 57 glucagon receptor 57 aminotransferase 57 hypermethylation 57 refractory prostate cancer 57 thromboembolic events 57 pharmacologic approaches 57 LUTS 57 MAPK pathway 57 EUS FNA 57 bladder tumors 57 MMP inhibitor 57 anterior uveitis 57 metastatic RCC 57 diabetic microvascular complications 57 erythropoiesis 57 chemoradiotherapy 57 mGluR2 NAM 57 Lodamin 57 platelet reactivity 57 hyperparathyroidism 57 selective agonist 57 glucose homeostasis 57 MALT lymphoma 57 anti angiogenic agent 57 neuroprotective 57 relapsed MM 57 ARIKACE ™ 57 Fenretinide 57 NMDA antagonist 57 etiologic 57 cell adhesion molecule 57 pathogenetic 57 muscular dystrophies 57 breast carcinomas 57 leukocyte adhesion 57 tumorigenicity 57 leukemia ALL 57 mucosal healing 57 proliferative retinopathy 57 renal disease 57 HIF PH inhibitors 57 AEGR 57 variceal hemorrhage 57 plasma lipid 57 PARP inhibition 57 allograft rejection 57 RAPAFLO R 57 ENaC 57 Alzheimer disease AD 57 M1 muscarinic 57 PHD2 57 R0 resection 57 PlGF 57 UVB induced 57 renal scarring 57 VA# [002] 57 dopaminergic therapy 57 recurrent glioblastoma multiforme 57 mTOR inhibitors 57 malignancies 57 thalidomide Thalomid 57 inflammatory cytokine 57 TTR amyloidosis 57 JUVISTA R Human 57 hepatic 57 HuR 57 cardiac repolarization 57 Archexin 57 plasma pharmacokinetics 57 thyroid dysfunction 57 antisense inhibitor 57 myocardial reperfusion 57 hypocalcaemia 57 virologic response 57 stratifying patients 57 hyperammonemia 57 immunotoxicity 57 metastatic prostate cancer 57 proteoglycan 57 epithelial cancers 57 prognostic variables 57 intestinal polyps 57 Degarelix 57 ischemia reperfusion injury 57 myeloproliferative neoplasms 57 hypoperfusion 57 neurosteroid 57 immune modulator 57 thromboembolic disease 57 Endothelial dysfunction 57 FLT3 57 CIMZIA ™ 57 collagen degradation 57 MGd 57 telomere shortening 57 CDK inhibitor 57 intestinal motility 57 carotid IMT 57 peptide BNP 57 JAK inhibitors 57 IL 1beta 57 carcinoid tumors 57 sarcosine 57 SIADH 57 interleukin IL -# 57 prostaglandin synthesis 57 proton MR spectroscopy 57 elevated uric acid 57 thrombocytosis 57 mycosis fungoides 57 tumor histology 57 carcinoid 57 prognostic indicators 57 ENMD # 57 serum cortisol 57 cerebral infarction 57 uveal melanoma 57 HPA axis 57 mucinous 57 Onconase 57 hypercalcemia 57 H. pylori eradication 57 APOPTONE 57 HepDirect prodrug 57 gastrointestinal motility 57 Dysregulation 57 neurological manifestations 57 APOL1 57 SCD1 57 androgen dependent 57 Candida infection 57 advanced adenoma 57 pressure natriuresis 57 mammographic density 57 serum biomarker 57 metastatic renal cell carcinoma 57 methylenetetrahydrofolate reductase 57 ANAVEX #-# [001] 57 nodal metastasis 57 antisense inhibitors 57 interferon IFN 57 immunomodulatory effects 57 lymphocyte counts 57 interleukin IL -6 57 cediranib 57 cardioprotection 57 Amplimexon 57 chromosomal rearrangement 57 PKC beta 57 Leydig cell 57 HDACi 57 vivo 57 miR #a [001] 57 ALA PDT 56 polycythemia vera PV 56 lobular carcinoma 56 mediated apoptosis 56 Kepivance 56 thromboembolic 56 liver cirrhosis 56 LTB4 56 TNF α 56 osteoblast differentiation 56 NAGS deficiency 56 parathyroid carcinoma 56 Tasimelteon 56 iron overload 56 Fibrosis 56 trodusquemine 56 hematopoietic malignancies 56 cysteamine 56 immunohistochemical 56 overactivation 56 Bosentan 56 breast cancer subtypes 56 chronic HBV infection 56 mitochondrial dysfunction 56 bFGF 56 renal cell carcinoma 56 antiphospholipid syndrome 56 Hepatocellular Carcinoma HCC 56 rs# [002] 56 P#Y# [001] 56 murine model 56 NF kappaB activation 56 flow mediated dilation 56 transthyretin 56 leiomyoma 56 CIPN 56 degenerative disorders 56 lactate dehydrogenase LDH 56 demonstrated antitumor activity 56 atrial arrhythmias 56 IAP inhibitor 56 mutant huntingtin protein 56 metaplasia 56 Prognostic factors 56 upregulating 56 signaling cascades 56 targeted radiotherapeutic 56 immunoregulation 56 histone acetylation 56 Chronic pancreatitis 56 lipid lowering therapies 56 Panzem R 56 NFkB 56 apremilast 56 adrenal function 56 MP4OX 56 axonal regeneration 56 chronic hepatitis 56 viral kinetics 56 pulmonary metastases 56 inverse agonist 56 Alpha lipoic acid 56 EGFR inhibitors 56 insulin sensitizing 56 ACh 56 lymph node metastasis 56 protein tyrosine phosphatase 1B 56 reflux esophagitis 56 ZFP Therapeutic 56 histopathological 56 cerebral ischemia 56 chemotherapy induced neutropenia 56 anti VEGF 56 biomarker 56 nicotinamide 56 immunopathology 56 inhibit platelet aggregation 56 Prostate Cancer Progression 56 NPM1 56 VEGF induced 56 endothelial nitric oxide 56 IGFBP 3 56 GRNCM1 56 PDE5A 56 endothelial activation 56 COX enzymes 56 impair fertility 56 coagulation cascade 56 UGT#A# 56 alpha1 antitrypsin deficiency 56 cardiac contractility 56 multivariate Cox 56 Alessandro Riva 56 hepatic lesions 56 mycophenolate mofetil 56 Interferon alpha 56 predictive biomarker 56 acute leukemias 56 somatostatin analog 56 EGFR receptor 56 atherosclerotic progression 56 cardiac toxicity 56 antitumor 56 Upregulation 56 pulmonary toxicity 56 PTP 1B 56 severe gastroparesis 56 hypophosphatasia 56 androgen receptor AR 56 KLF4 56 EBV infection 56 hedgehog signaling 56 HCV replication 56 cranial irradiation 56 myocardial necrosis 56 p#INK#a 56 genetic polymorphisms 56 chlamydial 56 acetabular dysplasia 56 androgen ablation 56 ERK signaling 56 dasatinib Sprycel 56 ductal adenocarcinoma 56 neuro degeneration 56 lesional 56 esophagogastric 56 gene amplification 56 hepatoma 56 glycosylated hemoglobin HbA1c 56 platelet aggregation 56 cervical dysplasia 56 catabolism 56 left ventricular diastolic 56 antiinflammatory 56 EGF receptor 56 steroidogenesis 56 intracranial hemorrhage ICH 56 pre malignant lesions 56 pathophysiologic 56 familial hypercholesterolemia FH 56 metabolic acidosis 56 idiopathic myelofibrosis 56 urine NGAL 56 cisplatin resistant 56 fibrosis cirrhosis 56 β amyloid 56 ABCB1 56 receptor agonists 56 Sjogren syndrome 56 PIK3CA 56 CaP 56 G6PD deficiency 56 metastases 56 lupus anticoagulant 56 HGPIN 56 leukotriene pathway 56 squamous cell lung cancer 56 Xanafide 56 costimulation 56 plasma triglycerides 56 GSTT1 56 Barrett Esophagus 56 castration resistant prostate cancer 56 thromboxane A2 56 PITX2 methylation 56 decompensated cirrhosis 56 antitumor effects 56 LDL oxidation 56 pulmonary metastasis 56 olmesartan 56 endothelial nitric oxide synthase 56 GHRH 56 gallstone disease 56 neuroprotective properties 56 monoclonal gammopathy 56 tumor lysis syndrome 56 NGAL 56 gastrin 56 predictive biomarkers 56 antihypertensive therapy 56 IGF IR 56 MS relapses 56 LHRH antagonists 56 gonadotrophin releasing hormone GnRH 56 vasospasm 56 diabetic retinopathy DR 56 hyperlipidemia 56 DNA methylation patterns 56 lipoatrophy 56 nAChR 56 elevated homocysteine 56 vascular disrupting agent 56 CMV infections 56 fosbretabulin 56 HeFH 56 osteosarcomas 56 HMG CoA reductase inhibitors 56 inflammatory mediators 56 capillary density 56 ectopic expression 56 lowering blood glucose 56 PRT# 56 oesophageal adenocarcinoma 56 Lp PLA 2 56 mGluR5 antagonist 56 neovascular diseases 56 2A receptor agonist 56 anti angiogenic drugs 56 CCX# 56 isoenzymes 56 gastric emptying 56 Interferon Beta 56 HAAH 56 HBV infection 56 Doxil ® 56 CRVO 56 RIP1 56 nucleotide analog 56 PCNSL 56 Akt signaling 56 HIF 1α 56 malignant ascites 56 Aplidin 56 p#NTR 56 postoperative morbidity 56 urinary excretion 56 endometrial carcinoma 56 liver resection 56 Idiopathic Pulmonary Fibrosis 56 HepG2 cells 56 parkinsonism 56 receptor antagonist 56 bortezomib Velcade 56 mevalonate 56 erlotinib Tarceva 56 biologic plausibility 56 Lymph node 56 PNP inhibitor 56 GW# [003] 56 P#X# 56 CTEPH 56 lymphomas 56 tissue oxygenation 56 Critical Limb Ischemia CLI 56 FDG uptake 56 β catenin 56 steroidogenic 56 penetrance 56 HBeAg negative 56 atherosclerosis regression 56 clinicopathological features 56 urothelial bladder cancer 56 Anti VEGF 56 fallopian tube cancers 56 lipid accumulation 56 CA4P 56 coronary stenosis 56 cytotoxic effects 56 physiologic mechanisms 56 triiodothyronine 56 hyperprolactinemia 56 thrombotic complications 56 EGFR HER 56 allogeneic HSCT 56 WT1 56 VKORC1 56 tafamidis 56 adipogenesis 56 STRIDE PD 56 EGFR mutations 56 microsatellite instability 56 basal cell nevus syndrome 56 radioiodine therapy 56 ACZ# 56 idiopathic pulmonary fibrosis IPF 56 muscarinic receptors 56 antifibrotic 56 neovascularisation 56 sinus bradycardia 56 Parkinson Disease PD 56 cholangiocarcinoma 56 myopathies 56 chemoresistance 56 TGF ß 56 vasodilatory 56 Helicobacter infection 56 prostate adenocarcinoma 56 overactive bladder symptoms 56 mineralocorticoid 56 CYP#B# 56 disease NAFLD 56 cognitive impairment 56 progesterone receptor PR 56 microglial 56 prostanoid 56 V#F mutation 56 PKCi 56 lymphangiogenesis 56 CMV disease 56 metastatic sarcoma 56 hemorrhagic complications 56 antisense inhibition 56 SYN# 56 bronchodilatory 56 EGFR pathway 56 kidney allograft 56 pancreatic carcinoma 56 adenomatous 56 PSN# [002] 56 liver disease 56 NF2 56 H. pylori infection 56 ALDH2 56 Liver biopsy 56 mtDNA mutations 56 renal insufficiency 56 diabetic peripheral neuropathy 56 renal cell carcinomas 56 aggrecan 56 Thrombocytopenia 56 T1a 56 lymphadenectomy 55 imatinib therapy 55 NQO1 55 Androgen receptor 55 abnormal uterine bleeding 55 hyperhomocysteinemia 55 metastasis 55 pigment epithelium derived 55 vascular abnormalities 55 superficial bladder cancer 55 CYP #A# 55 AGHD 55 cardiotoxic effects 55 CYP# [002] 55 protein tyrosine phosphatase 55 lipid metabolism 55 alanine aminotransferase 55 disc degeneration 55 vivo potency 55 postoperative pulmonary 55 Rheumatoid Arthritis RA 55 thyroid carcinoma 55 PTEN protein 55 INS# [001] 55 pathologic myopia 55 myelofibrosis polycythemia vera 55 rifalazil 55 cytokine receptor 55 recurrent prostate cancer 55 Fas ligand 55 leukotriene B4 55 lymphoma subtypes 55 Hydroxyurea 55 Diabetic Retinopathy 55 PGC 1α 55 TNF Tumor Necrosis Factor 55 VMAT2 55 hemodilution 55 heparanase 55 da mage 55 metastatic disease 55 papillary thyroid carcinoma 55 receptor blocker 55 systemically administered 55 sJIA 55 TNFα 55 prostate epithelial cells